BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Prognosis
10 results:

  • 1. Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
    Jiao J; Finberg KE; Jain D; Morotti R
    Pediatr Dev Pathol; 2023; 26(4):394-403. PubMed ID: 37334553
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Direct Conversion of Human Endothelial Cells Into liver cancer-Forming Cells Using Nonintegrative Episomal Vectors.
    Goya T; Horisawa K; Udono M; Ohkawa Y; Ogawa Y; Sekiya S; Suzuki A
    Hepatol Commun; 2022 Jul; 6(7):1725-1740. PubMed ID: 35220676
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic cancer.
    Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
    Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EPHB2 Activates β-Catenin to Enhance cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
    Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
    Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prolonged inhibition of hepatocellular carcinoma cell proliferation by combinatorial expression of defined transcription factors.
    Takashima Y; Horisawa K; Udono M; Ohkawa Y; Suzuki A
    Cancer Sci; 2018 Nov; 109(11):3543-3553. PubMed ID: 30220099
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.
    You Y; Que K; Zhou Y; Zhang Z; Zhao X; Gong J; Liu Z
    Mol Cells; 2018 Sep; 41(9):830-841. PubMed ID: 30145863
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
    Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
    Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
    Coulouarn C; Factor VM; Andersen JB; Durkin ME; Thorgeirsson SS
    Oncogene; 2009 Oct; 28(40):3526-36. PubMed ID: 19617899
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of HNFs and C/EBP alpha is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes.
    Ishiyama T; Kano J; Minami Y; Iijima T; Morishita Y; Noguchi M
    Cancer Sci; 2003 Sep; 94(9):757-63. PubMed ID: 12967472
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.